Literature DB >> 29800055

Improvement in Ulcerative Necrobiosis Lipoidica After Janus Kinase-Inhibitor Therapy for Polycythemia Vera.

Jonathan J Lee1, Joseph C English1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29800055     DOI： 10.1001/jamadermatol.2018.0756

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  4 in total

1.  Ulcerative necrobiosis lipoidica diabeticorum successfully treated with topical sevoflurane and punch grafting.

Authors:  Lucía Quintana-Castanedo; Lorena Recarte-Marín; Laura Pérez-Jerónimo; Elena Conde-Montero; Pablo de la Cueva-Dobao
Journal:  Int Wound J       Date:  2019-08-14       Impact factor: 3.315

2.  Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid.

Authors:  William Damsky; Katelyn Singh; Anjela Galan; Brett King
Journal:  JAAD Case Rep       Date:  2020-01-24

3.  Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream.

Authors:  Shannon Nugent; Alexandra J Coromilas; Joseph C English; Misha Rosenbach
Journal:  JAAD Case Rep       Date:  2022-08-27

Review 4.  The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature.

Authors:  Alice Wang; Katelyn Singh; Wael Ibrahim; Brett King; William Damsky
Journal:  Yale J Biol Med       Date:  2020-03-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.